All News
Filter News
Found 769,185 articles
-
Opthea To Present at the JMP Securities Life Sciences Conference
5/8/2023
Opthea Limited announced that Timothy E. Morris, the Company’s Chief Financial Officer will present at the JMP Securities Life Sciences Conference being held in New York City on May 15-16 2023.
-
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
5/8/2023
ANI Pharmaceuticals, Inc. announced business highlights and financial results for the three months ended March 31, 2023.
-
Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023
5/8/2023
Mallinckrodt plc, a global specialty pharmaceutical company, announced the presentation of results from two clinical studies for adults with hepatorenal syndrome with rapid reduction in kidney function1 treated with TERLIVAZ® for injection at Digestive Disease Week® 2023, taking place in Chicago, Ill.
-
Almirall’s First Quarter 2023 Results
5/8/2023
Almirall, S.A., the global biopharmaceutical company based in Barcelona, has announced its Q1 2023 financial results.
-
Pharvaris Reports First Quarter 2023 Financial Results and Provides Business Update
5/8/2023
Pharvaris reported financial results for the first quarter ended March 31, 2023 and provided a business update.
-
Transcenta to Present Two Clinical Trial Progress at ASCO 2023
5/8/2023
Transcenta Holding Limited announces that two posters for clinical trials of its ADCC enhanced anti-CLDN18.2 monoclonal antibody Osemitamab in combination with CAPOX or CAPOX plus Nivolumab for first-line G/GEJ cancer will be presented at 2023 American Society of Clinical Oncology Annual Meeting.
-
Devyser's clinical laboratory receives CLIA certification
5/8/2023
Devyser is announcing that the company's clinical testing laboratory in Roswell in Atlanta, Georgia, has received CLIA certification.
-
Cambridge University Hospitals Expands Virtual Care Program with Masimo W1™
5/8/2023
Masimo announced that Cambridge University Hospitals NHS Foundation Trust, U.K. is adopting the Masimo W1™ advanced health tracking watch for use in its telehealth and telemedicine programs.
-
Neuro3 Therapeutics Acquires Exclusive Worldwide Rights to Develop and Commercialize Clinical Stage KCNQ2 Activators from Lundbeck
5/8/2023
Neuro3 Therapeutics announced the signing of an exclusive, worldwide license and option agreement with Lundbeck, a leading pharmaceutical company focusing on the development of innovative medicines treating neurological and psychiatric diseases.
-
PharmaDrug Announces Cease Trade Order
5/8/2023
PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is announcing that the Ontario Securities Commission has issued a "failure to file" cease trade order in respect of the Company's securities under Multilateral Instrument 11-103 Failure-to- File Cease Trade Orders in Multiple Jurisdictions (the "CTO").
-
CorMedix Inc. To Report First Quarter 2023 Financial Results and Provide a Corporate Update on May 15, 2023
5/8/2023
CorMedix Inc. today announced that it will report its financial results for the first quarter ended March 31, 2023, after market close on Monday, May 15, 2023, and will host a corporate update conference call at 4:30pm Eastern Time.
-
Dentsply Sirona to Participate in Upcoming Investor Conferences
5/8/2023
DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced its participation at upcoming conferences.
-
Kintara Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference
5/8/2023
Kintara Therapeutics, Inc. today announced that its President and CEO, Robert E. Hoffman , will present a corporate overview at the Sidoti Micro-Cap Virtual Conference being held on May 10 – 11, 2023.
-
Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates
5/8/2023
Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Monday, May 15, 2023 at 8:30 a.m. Eastern Daylight Time to review first-quarter 2023 financials and provide corporate updates.
-
PharmAbcine to participate in BIO International Convention 2023
5/8/2023
PharmAbcine Inc. announced today that the company will participate in the upcoming BIO International Convention 2023.
-
Inhibikase Therapeutics to Report First Quarter Financial Results on May 15, 2023
5/8/2023
Inhibikase Therapeutics, Inc. today announced that it will report financial results for the first quarter ended March 31, 2023, on Monday, May 15, 2023, after the close of U.S. markets.
-
DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023
5/8/2023
DiaMedica Therapeutics Inc. announced today that its first quarter 2023 financial results will be released after the markets close on Monday, May 15th.
-
HeartSciences to Participate at the Inaugural EF Hutton Global Conference
5/8/2023
Heart Test Laboratories, Inc. today announces that CEO, Andrew Simpson, will participate at the Inaugural EF Hutton Global Conference being held May 10 – 11, 2023, at the Plaza Hotel in New York City.
-
Benitec Biopharma to Present at the JMP Securities Life Sciences Conference
5/8/2023
Benitec Biopharma Inc. today announced that Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will present at the JMP Securities Life Sciences Conference on Tuesday, May 16th, 2023 at 2:00 pm.
-
AltruBio Announces Poster Presentation at Digestive Disease Week Conference 2023
5/8/2023
AltruBio Inc. today announced that David T. Rubin, M.D., Professor of Medicine and Pathology at the University of Chicago and AltruBio Scientific Advisory Board member, will share a poster presentation on immune checkpoint enhancer (ICE), ALTB-168, during Digestive Disease Week®, taking place at McCormick Place in Chicago, IL, from May 6-9, 2023.